However, treatment approaches, such as the intravitreal injection of anti-vascular endothelial growth factor antibodies (anti-VEGF agents), laser-based coagulation, and photodynamic therapy, are used to reduce the severity of wet AMD [17]. The gene discussed is VEGFA; the disease is wet macular degeneration.